Login or sign up
For business

Azevan Pharmaceuticals

4.3ยท 12 reviews
Average ratingGreat
4.3/ 5

Based on 12 reviews

542%
442%
317%
20%
10%
Ask AI

Questions about Azevan Pharmaceuticals

Based on 12 reviews, listing data and website checks ยท updated 2 days ago

What is Azevan Pharmaceuticals?

Azevan Pharmaceuticals is a clinical-stage biopharmaceutical company developing first-in-class, orally bioavailable V1a receptor antagonists for neuropsychiatry, neurodegeneration, neurodevelopment, and brain injury. Their lead candidate SRX246 has demonstrated clinically meaningful reductions in pathological aggression in Huntington's Disease and Intermittent Explosive Disorder Phase 2 trials. The company is located at 115 Research Dr in Bethlehem, Pennsylvania.

What specific disorders is Azevan Pharmaceuticals targeting in its clinical pipeline?

The company's pipeline includes programs targeting Huntington's disease, Fragile X syndrome, intermittent explosive disorder, and mild traumatic brain injury. They are currently enrolling patients for a Phase 2 study in Fragile X syndrome starting Q1 2027. These programs aim to address severe symptom burdens where patients currently have few targeted treatment options.

Which specific products or compounds does Azevan Pharmaceuticals currently develop?

SRX246 is the lead candidate that has shown efficacy across two independent populations for pathological aggression. The company also develops SRX251, another CNS-penetrating V1a receptor antagonist that is orally bioavailable. Both compounds selectively block the effects of arginine vasopressin to normalize behavior.

What are the key statistics and funding details for Azevan Pharmaceuticals?

The company has raised $56M in funding from venture capital and non-dilutive sources. They have 55M+ TBI cases annually as a target area and focus on rare diseases like Fragile X and Huntington's disease. Their approach emphasizes mechanism-based therapy with a strong safety profile.

What do reviewers say about their experience with Azevan Pharmaceuticals?

Customers frequently praise the company's exceptional customer service, user-friendly website, and prompt delivery. Reviewers highlight the high quality and effectiveness of the products, noting the smooth and hassle-free experience. The Trustburn rating is 4.3 out of 5 from 12 reviews.

Where is Azevan Pharmaceuticals located and what does the address imply?

The company's headquarters is located at 115 Research Dr in Bethlehem, Pennsylvania. This location places them in the Lehigh Valley region, which may imply local partnerships or accessibility for patients in the northeastern US. The address is also listed as 116 Research Drive in some contexts.

How can a customer begin using Azevan Pharmaceuticals' services?

To get started, customers can visit the website at azevan.com to order medications. The process is described as smooth and hassle-free by reviewers. There is no mention of a free trial, but the website is noted as easy to navigate for ordering.

What is the underlying technology or mechanism used by Azevan Pharmaceuticals?

The company specializes in clinical compounds that selectively block arginine vasopressin effects. This mechanism is used to treat disorders of stress, mood, and behavior. The technology involves V1a receptor antagonism to normalize excess AVP signaling in threat-response circuits.

How does the V1a receptor antagonism mechanism work in Azevan Pharmaceuticals' treatments?

The company states that their approach involves circuit modulation to normalize behavior by reducing overactive vasopressin signaling. They aim to address circuit abnormalities without causing sedation or significant side effects. This targeted mechanism is designed for broad applicability in brain dysregulation.

Who exactly is Azevan Pharmaceuticals targeting with their current programs?

The company has a strong focus on rare diseases and severe symptom burdens. They target populations where patients have nothing targeted today, such as those with Huntington's disease and Fragile X syndrome. Success in these underserved populations is intended to open a path to broader CNS conditions.

What specific clinical trial designs or results are mentioned for Azevan Pharmaceuticals?

The company's website mentions a Phase 2 efficacy signal with SRX246 in pathological aggression. They also highlight a double-blind crossover design for their Fragile X study. These specific trial designs are mentioned as part of their clinical proof of concept.

What is the overarching mission and goal of Azevan Pharmaceuticals?

The company's mission is to translate vasopressin biology into novel CNS therapies. They aim to develop therapeutics for stress-related CNS disorders, including depression and PTSD. The goal is to provide targeted treatments for conditions currently managed with off-label antipsychotics.

What additional resources or sections are available on Azevan Pharmaceuticals' website?

The company's website footer mentions 'Expanded access' and 'Publications & News' as resources for patients and investors. They also provide a pipeline status update and senior management bios. These sections are designed to keep stakeholders informed about the company's progress.

How can I contact Azevan Pharmaceuticals?

You can reach Azevan Pharmaceuticals by phone at 6104191057.

How is Azevan Pharmaceuticals rated on Trustburn?

On Trustburn, Azevan Pharmaceuticals has a rating of 4.3 out of 5 based on 12 reviews.

AI-generated from reviews on this page. Verify anything important with the company directly.

Tony Gambill
Reviews 1

I recently had the pleasure of trying out some medications from Azevan Pharmaceuticals and I must say, I am thoroughly impressed. The website is user-friendly, the products are of high quality, and the customer service is outstanding. Will definitely be a repeat customer!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Azevan Pharmaceuticals

Azevan Pharmaceuticals, Inc., a clinical stage, small molecule drug development company, develops therapeutics to treat disorders of stress, mood, and behavior. The company specializes in clinical compounds that selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of major depression, intermittent explosive disorder, impulse control/anger disorders, and post-traumatic stress disorder (PTSD). Its products include SRX251 and SRX246 CNS-penetrating V1a receptor antagonists that are orally bioavailable. The company's SRX246 and SRX251 are developed for stress-related CNS disorders, including depression, PTSD, and intermittent explosive disorders. Azevan Pharmaceuticals, Inc. was formerly known as Serenix Pharmaceuticals, LLC and changed its name to Azevan Pharmaceuticals, Inc. in January 2002. The company was founded in 1999 and is based in Bethlehem, Pennsylvania.

Website
azevan.com
Address
115 Research Dr
Categories
Fine art